Ontology highlight
ABSTRACT:
SUBMITTER: Gu Y
PROVIDER: S-EPMC5581020 | biostudies-literature | 2017 Aug
REPOSITORIES: biostudies-literature
Gu Yu Y Chen Tianxiang T Li Guangliang G Xu Cong C Xu Zhenzhen Z Zhang Jing J He Kuifeng K Zheng Linyan L Guan Zhonghai Z Su Xinyun X Cao Jiang J Teng Lisong L
Oncotarget 20160804 32
Tamoxifen(TAM) is one of the most effective endocrine treatment for estrogen receptor(ER)-positive breast cancer, however drug resistance greatly limits benefit of it. Our purpose is to uncover the role of Beclin 1 in tamoxifen resistance and prognosis of ER positive breast cancer. We established a tamoxifen resistant ER-positive breast cancer cell subline MCF-7R presenting with higher Beclin 1 and human epidermal growth factor receptor 2(HER2) levels than MCF-7. Silencing Beclin 1 decreased lev ...[more]